Docetaxel in Treating Children With Recurrent Solid Tumors

NCT00002825 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Neuroblastoma
Sarcoma

Interventions

BIOLOGICAL: filgrastim
DRUG: docetaxel

Sponsor

National Cancer Institute (NCI)